A 2024 systematic review published in the American Journal of Sports Medicine concluded that "clinical data were limited, and in-human safety remains unknown." The FDA has classified BPC-157 as a Category 2 bulk drug substance, meaning it cannot be compounded by commercial pharmacies due to insufficient evidence of human safety
Effects of dietary glycine supplementation on the activities of enzymes for creatine synthesis in tissues Data on the activities of enzymes for creatine synthesis in tissues of Phase-II HSB are summarized in Table 3
Biochem J 288 : 977982 Rappa, G, Lorico, A, Flavell, RA & Sartorelli, AC (1997) Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins
My physician has prescribed it for me based on the eligibility requirements above
As always, consult with a healthcare professional before starting BPC-157 injections to ensure safe and effective use